{
  "id": 18185303,
  "title": "Functional analysis of small-molecule and protein binding domains using monomeric streptavidin-based two-component biosensors",
  "url": "https://urgent.news/2026/11/04/functional-analysis-of-small-molecule-and-protein-binding-domains",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-04T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.03.763809v1?rss=1"
  },
  "original_language": "en",
  "account": "Protein biosensors are crucial tools for analyzing and diagnosing molecular interactions. Typically, these biosensors employ two non-competing recognition domains, although binding affinity and specificity do not always guarantee compatibility with the overall biosensor structure. Researchers have now developed a modular platform that utilizes monomeric streptavidin (mSA2) as a substitute recognition domain. This innovation allows for quick functional assessment of potential binders within the biosensor framework, eliminating the need for an additional ligand-specific binding protein. The team established a chromatography-free method for extracting functional mSA2-based biosensor components from Escherichia coli bacteria. Through this approach, they successfully tested biotinylated small molecules, such as methotrexate and vitamin D3, as well as heart failure protein biomarkers galectin-3 and S100A7. The results showed that the ligand-dependent reporter biosensor activation was successful. This newly developed platform offers a scalable and efficient solution for rapid binder evaluation and biosensor prototyping, significantly simplifying the process of biosensor development using binding domains generated through directed evolution or computational protein design.",
  "summary": "Protein biosensors are important analytical and diagnostic tools that convert molecular recognition into measurable activity. Most common two-component biosensors require two non-competing recognition domains, yet binding affinity and specificity alone do not reliably predict their compatibility with the rest of the biosensor. We report a modular platform that exploits monomeric streptavidin…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}